The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

被引:120
|
作者
Savant, Sudha S. [1 ]
Sriramkumar, Shruthi [2 ]
O'Hagan, Heather M. [1 ,3 ]
机构
[1] Indiana Univ Sch Med, Med Sci, Bloomington, IN 47405 USA
[2] Indiana Univ, Cell Mol & Canc Biol Grad Program, Bloomington, IN 47405 USA
[3] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA
关键词
inflammation; epithelial ovarian cancer; cytokines; reactive oxygen species; growth factors; ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANCHORAGE-INDEPENDENT GROWTH; FACTOR RECEPTOR EXPRESSION; INTERLEUKIN-6; SERUM-LEVELS; C-REACTIVE PROTEIN; NF-KAPPA-B; LYSOPHOSPHATIDIC ACID; CELL-PROLIFERATION;
D O I
10.3390/cancers10080251
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Inflammation plays a role in the initiation and development of many types of cancers, including epithelial ovarian cancer (EOC) and high grade serous ovarian cancer (HGSC), a type of EOC. There are connections between EOC and both peritoneal and ovulation-induced inflammation. Additionally, EOCs have an inflammatory component that contributes to their progression. At sites of inflammation, epithelial cells are exposed to increased levels of inflammatory mediators such as reactive oxygen species, cytokines, prostaglandins, and growth factors that contribute to increased cell division, and genetic and epigenetic changes. These exposure-induced changes promote excessive cell proliferation, increased survival, malignant transformation, and cancer development. Furthermore, the pro-inflammatory tumor microenvironment environment (TME) contributes to EOC metastasis and chemoresistance. In this review we will discuss the roles inflammation and inflammatory mediators play in the development, progression, metastasis, and chemoresistance of EOC.
引用
收藏
页数:30
相关论文
共 50 条
  • [41] Decreasing ovarian cancer metastases and progression via restoration of microRNAs that target mediators of anoikis- and chemoresistance.
    Cittelly, Diana M.
    Cochrane, Dawn R.
    Howe, Erin N.
    Dimitrova, Irina
    Post, Miriam D.
    Russell, Broaddus R.
    Spillman, Monique A.
    Richer, Jennifer K.
    CANCER RESEARCH, 2013, 73
  • [42] Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
    Gu, Fei
    Zhang, Hao
    Yao, Liangqing
    Jiang, Shuheng
    Lu, Huan
    Xing, Xin
    Zhang, Cancan
    Jiang, Pengcheng
    Zhang, Rong
    ONCOLOGY LETTERS, 2019, 18 (01) : 561 - 570
  • [43] The influence of chronic low grade systemic inflammation on the progression of epithelial ovarian cancer
    Kerr, Amanda
    Kellenberger, Lisa
    Greenaway, James
    Petrik, Jim
    CANCER RESEARCH, 2011, 71
  • [44] A possible role for GSK3β in epithelial ovarian cancer chemoresistance by epigenetic regulation
    Cutter, Noelle L.
    Yacoub, Mena
    Lucito, Robert D.
    Dimitrova, Nevenka
    Lum, Elena
    Vigliotti, Michael
    Wrzeszczynski, Kazimierz
    Levine, Douglas A.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [45] E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
    Fabian Trillsch
    Sascha Kuerti
    Christine Eulenburg
    Eike Burandt
    Linn Woelber
    Katharina Prieske
    Kathrin Eylmann
    Leticia Oliveira-Ferrer
    Karin Milde-Langosch
    Sven Mahner
    British Journal of Cancer, 2016, 114 : 213 - 220
  • [46] E-CADHERIN FRAGMENTS AS POTENTIAL MEDIATORS FOR PERITONEAL METASTASIS IN ADVANCED EPITHELIAL OVARIAN CANCER
    Trillsch, F.
    Kuerti, S.
    Eulenburg, C.
    Burandt, E.
    Woelber, L.
    Prieske, K.
    Eylmann, K.
    Oliveira-Ferrer, L.
    Milde-Langosch, K.
    Mahner, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1516 - 1517
  • [47] E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
    Trillsch, Fabian
    Kuerti, Sascha
    Eulenburg, Christine
    Burandt, Eike
    Woelber, Linn
    Prieske, Katharina
    Eylmann, Kathrin
    Oliveira-Ferrer, Leticia
    Milde-Langosch, Karin
    Mahner, Sven
    BRITISH JOURNAL OF CANCER, 2016, 114 (02) : 213 - 220
  • [48] ROLE OF INFLAMMATION AND INFLAMMATORY MEDIATORS IN AIRWAYS DISEASE
    LAZARUS, SC
    AMERICAN JOURNAL OF MEDICINE, 1986, 81 (5A): : 2 - 7
  • [49] The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer
    Elkahwaji, Johny E.
    RESEARCH AND REPORTS IN UROLOGY, 2013, 5 : 1 - 10
  • [50] Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors
    Muttiah, Barathan
    Fuad, Nur Dina Muhammad
    Jaafar, Faizul
    Abdullah, Nur Atiqah Haizum
    BIOMEDICINES, 2024, 12 (08)